The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow‐up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation

The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study showed that 40 mg Olmesartan medoxomil (OM) versus placebo delayed microalbuminuria onset in patients with type 2 diabetes and normoalbuminuria.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Menne, Jan (VerfasserIn) , Ritz, Eberhard (VerfasserIn) , Ruilope, Luis M. (VerfasserIn) , Chatzikyrkou, Christos (VerfasserIn) , Viberti, Giancarlo (VerfasserIn) , Haller, Hermann (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 25 Apr 2014
In: Journal of the American Heart Association
Year: 2014, Jahrgang: 3, Heft: 2
ISSN:2047-9980
DOI:10.1161/JAHA.114.000810
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1161/JAHA.114.000810
Verlag, lizenzpflichtig, Volltext: https://www.ahajournals.org/doi/10.1161/JAHA.114.000810
Volltext
Verfasserangaben:Jan Menne, Eberhard Ritz, Luis M. Ruilope, Christos Chatzikyrkou, Giancarlo Viberti, Hermann Haller

MARC

LEADER 00000caa a2200000 c 4500
001 1733547401
003 DE-627
005 20240407193247.0
007 cr uuu---uuuuu
008 200922s2014 xx |||||o 00| ||eng c
024 7 |a 10.1161/JAHA.114.000810  |2 doi 
035 |a (DE-627)1733547401 
035 |a (DE-599)KXP1733547401 
035 |a (OCoLC)1341361199 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Menne, Jan  |d 1967-  |e VerfasserIn  |0 (DE-588)11570373X  |0 (DE-627)077416902  |0 (DE-576)290029597  |4 aut 
245 1 4 |a The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow‐up study  |b benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation  |c Jan Menne, Eberhard Ritz, Luis M. Ruilope, Christos Chatzikyrkou, Giancarlo Viberti, Hermann Haller 
264 1 |c 25 Apr 2014 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.09.2020 
520 |a The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study showed that 40 mg Olmesartan medoxomil (OM) versus placebo delayed microalbuminuria onset in patients with type 2 diabetes and normoalbuminuria. 
700 1 |a Ritz, Eberhard  |d 1938-2023  |e VerfasserIn  |0 (DE-588)106673386  |0 (DE-627)610528866  |0 (DE-576)311552501  |4 aut 
700 1 |a Ruilope, Luis M.  |e VerfasserIn  |4 aut 
700 1 |a Chatzikyrkou, Christos  |e VerfasserIn  |4 aut 
700 1 |a Viberti, Giancarlo  |e VerfasserIn  |4 aut 
700 1 |a Haller, Hermann  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |a American Heart Association  |t Journal of the American Heart Association  |d New York, NY : Association, 2012  |g 3(2014,2) Artikel-Nummer e000810, 13 Seiten  |h Online-Ressource  |w (DE-627)688605427  |w (DE-600)2653953-6  |w (DE-576)361844719  |x 2047-9980  |7 nnas 
773 1 8 |g volume:3  |g year:2014  |g number:2  |a The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow‐up study benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation 
856 4 0 |u https://doi.org/10.1161/JAHA.114.000810  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.ahajournals.org/doi/10.1161/JAHA.114.000810  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200922 
993 |a Article 
994 |a 2014 
998 |g 106673386  |a Ritz, Eberhard  |m 106673386:Ritz, Eberhard  |d 910000  |d 910100  |e 910000PR106673386  |e 910100PR106673386  |k 0/910000/  |k 1/910000/910100/  |p 2 
999 |a KXP-PPN1733547401  |e 3760028616 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Jan Menne, Eberhard Ritz, Luis M. Ruilope, Christos Chatzikyrkou, Giancarlo Viberti, Hermann Haller"]},"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Menne, Jan","given":"Jan","family":"Menne"},{"roleDisplay":"VerfasserIn","display":"Ritz, Eberhard","role":"aut","family":"Ritz","given":"Eberhard"},{"roleDisplay":"VerfasserIn","display":"Ruilope, Luis M.","role":"aut","family":"Ruilope","given":"Luis M."},{"given":"Christos","family":"Chatzikyrkou","role":"aut","roleDisplay":"VerfasserIn","display":"Chatzikyrkou, Christos"},{"display":"Viberti, Giancarlo","roleDisplay":"VerfasserIn","role":"aut","family":"Viberti","given":"Giancarlo"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Haller, Hermann","given":"Hermann","family":"Haller"}],"id":{"doi":["10.1161/JAHA.114.000810"],"eki":["1733547401"]},"origin":[{"dateIssuedDisp":"25 Apr 2014","dateIssuedKey":"2014"}],"title":[{"title_sort":"Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow‐up study","title":"The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow‐up study","subtitle":"benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation"}],"language":["eng"],"relHost":[{"language":["eng"],"corporate":[{"roleDisplay":"VerfasserIn","display":"American Heart Association","role":"aut"}],"recId":"688605427","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"American Heart AssociationJournal of the American Heart Association","note":["Gesehen am 09.01.14"],"titleAlt":[{"title":"Journal of the American Heart Association, Cardiovascular and Cerebrovascular Disease"},{"title":"JAHA"}],"part":{"text":"3(2014,2) Artikel-Nummer e000810, 13 Seiten","volume":"3","issue":"2","year":"2014"},"pubHistory":["1.2012 -"],"title":[{"title_sort":"Journal of the American Heart Association","subtitle":"JAHA","title":"Journal of the American Heart Association"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["2047-9980"],"eki":["688605427"],"zdb":["2653953-6"]},"origin":[{"dateIssuedDisp":"2012-","dateIssuedKey":"2012","publisher":"Association","publisherPlace":"New York, NY"}]}],"recId":"1733547401","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 22.09.2020"]} 
SRT |a MENNEJANRIRANDOMIZED2520